Form 4: MKS Inc. Director Sells 20,000 Shares Under 10b5-1 Plan

MKS Inc. Director Gerald G. Colella reported the sale of 20,000 shares of common stock across two transactions in February 2026, executed under a Rule 10b5-1 plan.

Summary

• Gerald G. Colella, a Director of MKS Inc. (MKSI), reported the sale of 20,000 shares of common stock.
• On February 20, 2026, 10,000 shares were sold at a weighted average price of $252.8999 per share.
• On February 24, 2026, an additional 10,000 shares were sold at a weighted average price of $253.9675 per share.
• Both transactions were executed indirectly by The Gerald G. Colella 2019 Trust.
• Following these sales, The Gerald G. Colella 2019 Trust beneficially owns 40,017 shares indirectly.
• Gerald G. Colella also directly owns 8,216.927 shares of common stock.
• The sales were conducted pursuant to a pre-arranged Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sales were pre-planned under a 10b5-1 plan, which mitigates any negative sentiment typically associated with insider selling, as it suggests a personal financial management decision rather than a reaction to company-specific news.

Positives

• The transactions were executed under a Rule 10b5-1(c) plan, indicating pre-scheduled sales for diversification or liquidity rather than a reaction to new material information, which enhances transparency.

Negatives

• Insider sales, even when planned, can sometimes be perceived by the market as a lack of confidence, although this is mitigated by the 10b5-1 plan.

Industry Context

StockSavvy.ai notes that insider sales, particularly when executed under a pre-arranged Rule 10b5-1 plan, are a common practice for executives and directors to manage personal finances, diversify portfolios, or meet liquidity needs. Such planned sales typically do not signal a change in the company's fundamental outlook or performance, distinguishing them from opportunistic sales that might raise concerns.

Related Party Transactions

• The reported sales were executed by The Gerald G. Colella 2019 Trust, which is an indirect beneficial owner related to Director Gerald G. Colella.

Stakeholder Impact

• Shareholders: Minimal direct impact, as the sales were pre-planned and do not necessarily reflect a change in the company's operational performance or future prospects.

Key Dates

Recommendation

The reported sales by Director Gerald G. Colella were executed under a pre-arranged Rule 10b5-1 plan, which typically indicates a planned diversification or liquidity event rather than a reaction to new material information. Therefore, this transaction alone does not suggest a fundamental shift in the company's prospects that would warrant a change from a 'hold' recommendation.

Keywords

MKS Inc, MKSI, insider trading, Form 4, stock sale, director, Gerald G. Colella, 10b5-1 plan